3.9 Article

RAAS inhibitors in COVID-19: not all are created equal. Telmisartan is the one

Journal

Revista Portuguesa de Cardiologia
Volume -, Issue -, Pages -

Publisher

Elsevier BV
DOI: 10.1016/j.repc.2023.08.005

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available